Increased intracellular accumulation of macrophage inflammatory protein 1β and its decreased secretion correlate with advanced HIV disease

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 5, 1999, Pages 420-422

  Tartakovsky, Boris ^a   Turner, Dan ^a   Vardinon, Nurith ^a   Burke, Michael ^a   Yust, Israel ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Chemokines; HIV; Intracellular cytokines; Viral load

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033560737     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199904150-00002     Document Type: Article

References (13)

1. Zanussi S, Andrea MD, Simonelli C, Tirelli U, De Paoli P. Serum levels of RANTES and MIP-1α in HIV positive long term survivors and progressor patients. AIDS 1996;10:1431-2.
2. Clerici M, Balotta C, Trabattoni D, et al. Chemokines production in HIV seropositive long term asymptomatic individuals. AIDS 1996;10:1432-33.
3. McKenzie SW, Dallalio G, North M, Frame P, Means TR Jr. Serum chemokine levels in patients with non progressing HIV infection. AIDS 1996;10:29-33.
4. Ullum H, Lepri AC, Victor J, et al. Production of β-chemokines in human immunodeficiency virus infection: evidence that high levels of macrophage inflammatory protein-1β are associated with a decrease risk of HIV disease progression. J Infect Dis 1998;177: 331-6.
5. Aukrust P, Müller F, Froland S. Circulating levels of RANTES in human immunodeficiency virus type I infection: effect of potent antiretroviral therapy. J Infect Dis 1998;177:1091-6.
6. Zagury D, Laghar A, Chams V, et al. C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci USA 1998;95:3857-61.
7. Tartakovsky B, Burke M, Vardinon N, et al. Increased intracellular MIP1β correlates with advanced HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:1-5.
8. Chen J-D, Bai X, Yang A-G, Cong Y, Chen S-Y. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy. Nat Med 1997;10:1110-16.
9. Foey AD, Crawford A, Hall ND. Modulation of cytokine production by human mononuclear cells following impairment of Na, K-ATPase activity. Biochim Biophys Acta 1997;1355:43-9.
10. Hide I, Toriu N, Nuibe T, Inoue A, Yamamoto S, Nakata Y. Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. J Immunol 1997; 159:2932-40.
11. Smith BL, Krushelnycky BW, Mochly Rosen D, Berg P. The HIV nef protein associates with protein kinase C theta. J Biol Chem 1996;271:16753-7.
12. Kim CH, Gollapudi S, Kim A, Lee T, Gupta S. Role of protein kinase C-beta isozyme in activation of latent human immunodeficiency virus type 1 in promonocytic U1 cells by phorbol-12-myristate acetate. AIDS Res Hum Retroviruses 1996;12:1361-6.
13. Bisset LR, Rothen M, Joller-Jemelka HL, Dubs RW, Grob PJ, Opravil M. Changes in circulating levels of the chemokines macrophage inflammatory proteins 1α and 1β, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. AIDS 1997;11:485-91.